[Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
The serological findings of three patients suffering from liver cirrhosis and hepatitis accompanied by immunohemolytic anemia (IHA) are described. As a cause of the observed hemolyses the administration of (+)-Cyanidanol-3 (Catergen) was supposed. In contrast to three cases reported in literature antibodies against Catergen were not detectable, therefore a causal connexion between the development of IHA and Catergen could not be proved.
D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D001578:Benzopyrans / Q000009:adverse effects*; D002392:Catechin / Q000009:adverse effects* / Q000627:therapeutic use; D004912:Erythrocytes / Q000187:drug effects; D006386:Hemagglutination Tests; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D010400:Penicillin G / Q000494:pharmacology
D001578:Benzopyrans; D002392:Catechin; D010400:Penicillin G
Immunhämatologische Untersuchungen über Zusammenhänge zwischen (+)-Cyanidanol-3-(Catergen)-Therapie und hämolytischer Anämie.